|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Share-based compensation expense | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Amortization of deferred financing costs | |||||
| Amortization of investments | |||||
| Change in fair value of contingent consideration | |||||
| Intangible asset impairment | |||||
| Acquired in-process research and development expense | |||||
| Loss on debt extinguishment | |||||
| Other non-cash adjustments | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Other current assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Other noncurrent assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of available-for-sale securities | |||||
| Sales and maturities of available-for-sale securities | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Acquisitions, including in-process research and development | |||||
| Proceeds from capital grant | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from revolving credit facility, net of financing costs | |||||
| Payments on debt, leases and financing obligation | |||||
| Proceeds from financing obligation | |||||
| Payment of financing costs and bank fees | |||||
| Proceeds from stock option exercises | |||||
| Shares repurchased for payment of taxes on stock awards | |||||
| Proceeds from issuance of common stock under employee stock purchase plan | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents—beginning of period | |||||
| Cash and cash equivalents—end of period | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net of refunds | |||||
| Non-cash investing and financing activities: | |||||
| Accrued purchases of property and equipment | |||||
Loading...